CASK
MGP Ingredients, Inc.
CASK lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
CASK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Weak |
CASK's revenue, profitability, cash flow and balance sheet are all currently under pressure.
CASK PE Valuation
CASK has no meaningful PE right now: it lost money over the past year.
CASK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CASK's earnings to grow and its profitability to improve, with its revenue holding steady.
CASK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.72 | — |
| Q3 2026 | -$11.66 | -$11.04 |
| Q2 2026 | -$11.27 | -$11.01 |
| Q1 2026 | -$11.15 | -2330% |
| Q4 2025 | -$4.99 | -420% |
| Q3 2025 | -$0.62 | -113% |
| Q2 2025 | -$0.26 | -106% |
| Q1 2025 | $0.50 | -88% |
| Q4 2024 | $1.56 | -68% |
CASK lost $11.66 per share over the past year, and its loss has widened in each of the last eight quarters.
CASK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $117.9M | -9.9% |
| Q2 2026 | $124.4M | -15% |
| Q1 2026 | $106.4M | -13% |
| Q4 2025 | $138.3M | -23% |
| Q3 2025 | $130.9M | -19% |
| Q2 2025 | $145.5M | -24% |
| Q1 2025 | $121.7M | -29% |
| Q4 2024 | $180.8M | -16% |
CASK's revenue has slid since its 2023 peak: $118M last quarter, down 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -5.9 points |
| Q2 2026 | 14% | +0.2 points |
| Q1 2026 | -163% | -162 points |
| Q4 2025 | -98% | -81 points |
| Q3 2025 | 16% | -4.1 points |
| Q2 2025 | 14% | -8.8 points |
| Q1 2025 | -0.6% | -18 points |
| Q4 2024 | -17% | -37 points |
CASK's operating margin was 10% last quarter, down 5.9 points from the same quarter a year ago.
CASK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $27.2M | -1.3% |
| Q2 2026 | -$52.2M | -$51.6M |
| Q1 2026 | $1.2M | -95% |
| Q4 2025 | $24.3M | +133% |
| Q3 2025 | $27.6M | +13% |
| Q2 2025 | -$557K | +$855K |
| Q1 2025 | $24.8M | +$27.2M |
| Q4 2024 | $10.4M | -53% |
CASK generated $527,000 in free cash flow over the past year, down 99% from the year before.
CASK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 7.6x | High |
| Q2 2025 | 6.3x | High |
| Q1 2025 | 4.1x | High |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 1.6x | Healthy |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | 1.8x | Healthy |
| Q4 2023 | 1.6x | Healthy |
CASK's net debt is about 7.6 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
CASK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.2 | Neutral |
| Stochastic | 72.8 | Neutral |
CASK's weekly RSI is 50 (neutral) and its Stochastic is 73 (neutral).
CASK PE vs Consumer Defensive Sector
| Metric | CASK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
CASK has no meaningful PE right now: it lost money over the past year.
CASK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.3 | 11% above |
| 20 week MA | $16.2 | 4.7% above |
| 50 week MA | $19.1 | 11% below |
| 100 week MA | $24.5 | 31% below |
| 200 week MA | $56.8 | 70% below |
CASK has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 70% below its 200-week average.
CASK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.9 | $47.4 | -3.1% |
| 2021 | $47.4 | $86.8 | +83% |
| 2022 | $86.8 | $109.4 | +26% |
| 2023 | $109.4 | $98.5 | -10% |
| 2024 | $98.5 | $39.5 | -60% |
| 2025 | $39.5 | $24.2 | -39% |
| 2026 YTD | $24.2 | $17.0 | -30% |
CASK has finished three years in a row lower, and it's down 30% so far in 2026.